The most frequently occurring tumor locations (with the highest number of functionally significant mutations in the SLC34A2 gene) were the skin, lung, bowel, and uterus, with 23, 22, 17, and 17 unique mutations respectively (Supplementary Table S4). The gene discussed is SLC34A2; the disease is neoplasm.